CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for American Biomed, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

American Biomed, Inc.
14800 Quorum Dr., No. 200
Dallas, TX  75240  United States

This company is no longer actively traded on any major stock exchange.

Business Summary
American Biomed, Inc. develops, manufactures and markets medical, surgical and diagnostic devices, primarily through its subsidiary, Cathlab Corporation. The Company's primary technology is directed at interventional cardiology, endovascular surgery and minimally invasive surgical devices. The principal products are atherectomy catheters, stents, clot filters, 100%-silicone balloon catheters and drug delivery catheter systems. The Company's primary business strategy is to design and develop minimally invasive medical devices to treat atherosclerotic disease. Cathlab has 10 FDA-approved balloon catheters, seven of which are currently being marketed within the United States and abroad.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/200012/31/1999-YesYes-Yes

Business Names
Business Name
ABMIQ
American Biomed, Inc.
OmniCath

General Information
Outstanding Shares: 45,144,829 (As of 3/31/2000)
Shareholders: 4,200
Stock Exchange: OTC
Federal Tax Id: 760136574


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023